News
News from us and our partners
Tags
Topics
0 results
- News
Rezera announces phase 1 results for Trabzanoflast, which was generally well tolerated and demonstrated high central nervous system exposure (CNS)
- News
GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates
- News
Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update
- News
Redx Announces Design of ROCKETEER Phase 2 Trial for RXC008 in Fibrostenotic Crohn’s Disease
- News
Sofinnova Partners closes oversubscribed €82 million Sofinnova MD Start IV fund to create the next generation of medtech companies
- News
Julier Medical appoints medtech industry veteran Will Martin as President and Chief Executive Officer
- News
AFYREN announces its 2026 half-year financial results
- News
Hemab Therapeutics strengthens Board of Directors with appointment of Keli Walbert
- News
ProQR names Chris Hart as Chief Data and AI Officer; Thomas Wolf to join the Board of Directors as strategic AI advisor
- News
Sensorion reports 2026 half-year results and provides corporate update
- News
HighLife Raises $90+million to start its US Pivotal Study and accelerate commercial expansion in Europe
- News
SEK 75 million equity round bolsters enginzyme's commercial strategy
- News
Before the breakthrough: Sofinnova's decade-long bet on HighLife
- News
Abivax presents business updates and first-half financial results
- News
GlycoEra appoints Andrea Matthews as Chief Business Officer to support next phase of company growth